PepsiCo plays around when it tries to adjust the size of a bag of chips in an inflationary environment. It's what's called a glucagon-like peptide-1 or GLP-1 agonist. It targets both the GLP-1 hormone that Ozempic does, but also another one called GIP, it stands for glucose-dependent insulinotropic polypeptide, that's a mouthful.